financetom
Business
financetom
/
Business
/
US energy mergers may slow in 2025 as deal sizes shrink, says Enverus
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US energy mergers may slow in 2025 as deal sizes shrink, says Enverus
Jan 21, 2025 6:49 AM

(Reuters) - The pace of U.S. upstream public-to-public mergers could slow in 2025 from their recent average of five per year along with a fall in deal sizes, according to a report from energy analytics firm Enverus that was released on Tuesday.

The consolidation trend in the U.S. energy sector, which triggered deals amounting to $250 billion in 2023, stretched into 2024 and is expected to extend into this year too as companies strive to augment their oil and gas reserves.

The wave of deals emptied pocketbooks and left fewer companies on offer, while some announced combinations have been delayed, either by antitrust regulations or by contract arbitration challenges.

The need for scale would motivate small and mid-cap E&Ps (upstream companies) to explore M&As despite deal sizes potentially falling and the break-evens of acquired inventory rising, Enverus analysts said in the report.

"The pool of available remaining private equity assets is largely smaller, higher on the cost curve or both," they said.

Cost-saving measures such as long laterals - the horizontal portion of an oil well - will be important in improving the economics of the land available for drilling, with a nearly $5 per barrel breakeven per mile.

The longer laterals would be key in driving down well costs as they did in 2024, with a broader utilization of three-mile laterals and some four-mile wells by select operators, according to the report.

It also expects well costs to hold flat in 2025 after a nearly 10% decline in per-foot well expenditure the previous year.

Producers were extending their wells to be three miles long in August 2024, boosting production by fracking several wells at once, according to industry experts as well as company executives.

"We expect rigs and completion crews will continue making efficiency gains in 2025, placing downward pressure on overall equipment utilization," the Enverus analysts said. Most activity would be weighted to public companies that prefer top-spec rigs and electric frac equipment.

Overall, Enverus Intelligence Research analysts expect Brent prices to average $80/bbl, assuming OPEC+ will unwind cuts only if they don't pressure prices lower, and the demand from China stays flat throughout 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Take-Two Interactive Shares Are Trading Higher Monday: What's Going On?
Take-Two Interactive Shares Are Trading Higher Monday: What's Going On?
Sep 29, 2025
Take-Two Interactive Software, Inc. ( TTWO ) shares are trading higher Monday in sympathy with Electronic Arts, Inc. ( EA ) , which announced it will be acquired for $55 billion. Investors often view large acquisitions in the video game industry as a sign of broader strength in the sector, which can lift peer companies like Take-Two. The premium paid...
Mexico meat sector decries new livestock movement rules, ivermectin requirement to battle screwworm
Mexico meat sector decries new livestock movement rules, ivermectin requirement to battle screwworm
Sep 29, 2025
MEXICO CITY (Reuters) -Mexico's meat industry is pushing back against new government regulations on livestock movement as tensions with the United States heat up over an outbreak of the flesh-eating screwworm parasite. Restricting movement of livestock from the south to the north of the country threatens the viability of a sector that generated $192 billion in 2024, Mexican meat chamber...
MoonLake's Immunotherapeutics Stock Plummets After Phase 3 Data Readouts
MoonLake's Immunotherapeutics Stock Plummets After Phase 3 Data Readouts
Sep 29, 2025
MoonLake Immunotherapeutics ( MLTX )‘ stock price fell off a cliff Monday after it reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials. The trials used HiSCR75—a 75% reduction in abscess and inflammatory nodule count with no increase in abscesses or draining tunnels—as the primary endpoint. Key secondary endpoints included HiSCR50 response rates and improvements in Dermatology Quality...
Outlook Therapeutics Plans to Resubmit ONS-5010 Biologics License Application Before Year-End
Outlook Therapeutics Plans to Resubmit ONS-5010 Biologics License Application Before Year-End
Sep 29, 2025
02:33 PM EDT, 09/29/2025 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said Monday it expects to resubmit its biologics license application for ONS-5010, an investigational treatment for wet macular degeneration, after completing a Type A meeting with the US Food and Drug Administration. After reviewing the agency's feedback and meeting minutes, the company said it expects to resubmit the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved